Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378336 · ClinicalTrials.gov registry record
Psoriatic Arthritis Research Collaborative: Biologic Sub-Study
A clinical trial of Psoriatic Arthritis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 171
- Enrollment target
- 4
- Study locations
NCT03378336: Completed study of Psoriatic Arthritis, sponsored by University of Pennsylvania.
NCT03378336 is a study of Psoriatic Arthritis that has completed, run by University of Pennsylvania. The registered enrollment target is 171 participants, below the 849-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03378336, a study of Psoriatic Arthritis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
- 4
- Study locations
Study Summary
Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data necessary to design a pragmatic trial in PsA.
Primary Outcome
Patient's perception of response to therapy as related to patient functionality. Measured by a change in RAPID3 score from baseline to 3 month visit. RAPID3 (Routine Assessment of Patient Index Data 3) is a pooled index of the 3 patient-reported American College of Rheumatology Core Data Set measures: function, pain, and patient global estimate of status. Each of the 3 individual measures is scored 0 to 10, for a total of 30. Disease severity may be classified on the basis of RAPID3 scores: \>1
Conditions Studied
Study Locations (4)
New York
- NYU School of Medicine - New York
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- Hospital at the University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2017-12-31 |
| Est. Completion | 2023-08-16 |
What the finished NCT03378336 record still lists
NCT03378336 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 849-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT03378336 reports a single indexed study location in New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03378336 about?
NCT03378336 is a clinical study titled "Psoriatic Arthritis Research Collaborative: Biologic Sub-Study". Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data neces...
What is the current status of trial NCT03378336?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2017-12-31. Estimated completion is 2023-08-16.
What conditions does trial NCT03378336 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
Who is sponsoring clinical trial NCT03378336?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378336 being conducted?
This trial has 4 study locations across New York, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03378336's enrollment target sits among peer trials
171 30th of 48 higher than 19 of 48 other Psoriatic Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psoriatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Stronger Together Psoriatic Arthritis Wellness Study
RECRUITING
-
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI